drugset / Trial / NCT01424176

Dexpramipexole Renal PK Study

NCT01424176

Phase 1 Completed 36 enrolled Knopp Biosciences
Non-randomizedParallel-groupOpen-labelBasic science

Summary

This is a multicenter, open-label, single-dose, PK and safety study in subjects with various stages of renal impairment.

Timeline

Start
2011-07
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexpramipexole Small molecule Oral